Evlo stocks.

Evelo Biosciences Inc (EVLO) stock is trading at $4.12 as of 11:07 AM on Tuesday, Jul 18, an increase of $0.57, or 16.06% from the previous closing price of $3.55. The stock has traded between $3.65 and $4.48 so far today. Volume today is less active than usual. So far 498,170 shares have traded compared to average volume of 961,599 …

Evlo stocks. Things To Know About Evlo stocks.

Nov 22, 2023 · During the last day, the stock moved $0.0291 between high and low, or 7.27%. For the last week the stock has had daily average volatility of 19.21%. Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set. Trading Expectations (EVLO) For The Upcoming Trading Day Of Thursday 30th For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. In the past 60 days, the estimate for Allogene Therapeutics’ 2024 earnings per share narrowed from $2.22 to $2.21.Nov 20, 2023 · EVLO) stock’s latest price update. The stock of Evelo Biosciences Inc (NASDAQ: EVLO) has decreased by -32.65 when compared to last closing price of 0.73.Despite this, the company has seen a gain of 62.37% in its stock price over the last five trading days. Benzinga reported 2023-10-20 that The most oversold stocks in the health care sector ...

Evelo Biosciences last released its earnings data on November 9th, 2023. The reported ($0.66) earnings per share for the quarter, topping the consensus estimate of ($1.34) by $0.68. Evelo Biosciences has generated ($13.29) earnings per share over the last year ( ($13.29) diluted earnings per share). Evelo Biosciences has not formally confirmed ...Stock analysis for Evelo Biosciences Inc (EVLO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

October 18, 2023 at 11:21 AM · 3 min read. Shares of Evelo Biosciences EVLO plummeted 58.8% on Tuesday after its management announced disappointing top-line results from a mid-stage study ...Oct 20, 2023 ... LMDX Price Action: Shares of LumiraDx fell 11.3% to close at $0.0930 on Thursday. Evelo Biosciences, Inc. EVLO. Evelo Biosciences reported the ...

EVLO's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Biotechnology industry, which ranks 121 out of 146 industries, Evelo Biosciences Inc ranks higher than 11% of stocks.What's Happening with EVLO Stock Today. Evelo Biosciences Inc (EVLO) stock is unmoved 1.49% while the S&P 500 has gained 0.96% as of 1:37 PM on Thursday, Apr 13. EVLO is unmoved $0.00 from the previous closing price of $0.16 on volume of 370,184 shares. Over the past year the S&P 500 is lower by -7.09% while EVLO has fallen -93.80%.Updated 27 Apr 2023. Fact Checked. Disclaimer. The Evelo Biosciences Inc (NASDAQ: EVLO) stock price soared 86.1% despite yesterday’s clinical updates saw its stock price fall 32.9%. Today’s rebound can be attributed to a shift in investor sentiment as busters stepped in and bought Evelo shares despite yesterday’s disappointing trial results.Shares of EVLO stock opened at $0.45 on Thursday. The stock has a market cap of $8.43 million, a P/E ratio of -0.03 and a beta of 1.81. The company has a fifty day moving average price of $2.66 ...EVLO stock is up 51.3% as of Tuesday morning. Investors seeking out more of the most recent stock market news will want to stick around! We have all of the hottest stock market news that traders ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Nov 28, 2023 · Evelo Biosciences Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.400 per share for the current fiscal year. Evelo Biosciences Inc does not currently pay a dividend.

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.EVLO's stock price has decreased by -99.11% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for EVLO stock stock is $10, which predicts an increase of 2,431.00%.Evelo Biosciences Inc EVLO released top-line results from its Phase 2 clinical study with EDP2939 in moderate psoriasis. EDP2939 is a next-generation product candidate based on previously reported ...Evelo Biosciences (EVLO) Stock Price Performance. Evelo Biosciences (EVLO) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Evelo Biosciences Inc (EVLO) stock is trading at $3.11 as of 10:17 AM on Friday, Oct 13, an increase of $0.10, or 3.16% from the previous closing price of $3.01. The stock has traded between $3.05 and $3.39 so far today. Volume today is below average.Of the 34 institutional investors that purchased Evelo Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Flagship Pioneering Inc. ($27.40M), FMR LLC ($10.46M), State of Michigan Retirement System ($2.97M), CVI Holdings LLC ($2.05M), Vanguard Group Inc. …

EVLO support price is $2.92 and resistance is $3.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVLO stock will trade within this expected range on the day. View a ...Their EVLO share price targets range from $40.00 to $100.00. On average, they predict the company's share price to reach $70.00 in the next twelve months. This …Analysts gave the Evelo Biosciences Inc (EVLO) stock a consensus recommendation rating of an Underweight, calculated at a mean rating of 4.00. If we narrow down to specifics, the data shows that 1 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended EVLO as a …Overview Evelo Biosciences Inc. U.S.: Nasdaq after hours $ 0.4890 EVLO 0.01 1.85% Nov 24, 2023 4:47 p.m. EST After Hours Vol. 143.28K Price at close $ 0.4801 …Institutional Ownership and Shareholders. Evelo Biosciences Inc (US:EVLO) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 316,819 shares. Largest shareholders include Norges Bank, and Mayo Clinic . Evelo Biosciences …Nov 4, 2023 ... BREAKDOWN CONTINUES | $EVLO STOCK ANALYSIS | EVELO BIOSCIENCES STOCK. 10 views · 2 days ago UNITED STATES ...more. MAKING MONEY WITH WALL ...

Discover historical prices for EVO stock on Yahoo Finance. View daily, weekly or monthly format back to when Evotec SE stock was issued.

For their last quarter, Evelo Biosciences (EVLO) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-1.34 per share. This reflects a positive earnings surprise of 50. ...Evelo Biosciences, Inc. Common Stock (EVLO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Evelo Biosciences, Inc. Common Stock (EVLO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Evelo Biosciences Inc. (EVLO) stock price, news, historical charts, analyst ratings and financial information from WSJ.Get the latest Evotec SE (EVO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.With this news comes heavy trading of EVLO stock as some 11 million shares change hands. That’s a massive surge compared to the company’s daily average trading volume of about 379,000 shares ...

Nov 24, 2023 · EVLO is trading at a 54% discount. Price $0.48 Nov 24, 2023 Fair Value $4.36 Nov 24, 2023 Uncertainty Extreme 1-Star Price $93.93 5-Star Price $7.34

View Evelo Biosciences, Inc EVLO investment & stock information. Get the latest Evelo Biosciences, Inc EVLO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Analyst's Opinion · Consensus Rating. Evelo Biosciences has received a consensus rating of Reduce. · Price Target Upside/Downside. According to analysts' ...EVLO | Complete Evelo Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Evelo Biosciences, Inc. Stock technical analysis with dynamic chart and Delayed Quote | Nasdaq: EVLO | Nasdaq. ... EVLO US2997342025 Market Closed - Nasdaq. Other stock markets. 04:00:00 2023-12-01 pm EST 5-day change 1st Jan Change 0.3951 USD -1.25% -17.7% -98.77% Nov. 21: Evelo Biosciences, Inc. Announces …May-17-23 12:00PM. What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock. (Zacks) May-16-23 06:00AM. Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry. (PR Newswire) May-10-23 08:42AM. Evelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \.For their last quarter, Evelo Biosciences (EVLO) reported earnings of -$0.66 per share, beating the Zacks Consensus Estimate of $-1.34 per share. This reflects a positive earnings surprise of 50. ...Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. 229.64M. 59.82%. Get the latest Evolution AB (publ) (EVO) real-time quote ... Evelo Biosciences, Inc. (EVLO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. As of 10:01AM EST. Market open. See Evelo Biosciences, Inc. (EVLO) stock analyst estimates, including earnings ...Analyst Recommendations on Evelo Biosciences, Inc. TD Cowen Downgrades Evelo Biosciences to Market Perform From Outperform. Oct. 18. MT. Morgan Stanley Adjusts Evelo Biosciences' Price Target to $10 From $2, Keeps Equalweight Rating. Jul. 26. MT. Chardan Downgrades Evelo Biosciences to Neutral From Buy, Cuts Price Target to $2.50 From $5. Nov. 16. Nov 28, 2023 · A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ...

Overview Evelo Biosciences Inc. U.S.: Nasdaq after hours $ 0.4890 EVLO 0.01 1.85% Nov 24, 2023 4:47 p.m. EST After Hours Vol. 143.28K Price at close $ 0.4801 -0.1284 -21.10% Nov 24, 2023 1:00...Evelo Biosciences last released its earnings data on November 9th, 2023. The reported ($0.66) earnings per share for the quarter, topping the consensus estimate of ($1.34) by $0.68. Evelo Biosciences has generated ($13.29) earnings per share over the last year ( ($13.29) diluted earnings per share). Evelo Biosciences has not formally confirmed ...Evelo Biosciences Inc stock price live 0.40, this page displays NASDAQ EVLO stock exchange data. View the EVLO premarket stock price ahead of the market session or …Instagram:https://instagram. companies like coinbasecheapest penny stockdollar6 gold royalty stockgcow etf The stock of Evelo Biosciences Inc (EVLO) has seen a -22.74% decrease in the past week, with a -87.68% drop in the past month, and a -96.02% decrease in the past quarter. The volatility ratio for the week is 28.72%, and the volatility levels for the past 30 days are at 21.29% for EVLO. The […] ung marketwatchbp for seniors The intrinsic value of EVLO. FMR LLC ( Trades, Portfolio) acquired 2,325,827 shares of Evelo Biosciences Inc ( NASDAQ:EVLO) on July 31, 2023, at a price of $10.47 per share. This transaction ...Analyst Recommendations on Evelo Biosciences, Inc. TD Cowen Downgrades Evelo Biosciences to Market Perform From Outperform. Oct. 18. MT. Morgan Stanley Adjusts Evelo Biosciences' Price Target to $10 From $2, Keeps Equalweight Rating. Jul. 26. MT. Chardan Downgrades Evelo Biosciences to Neutral From Buy, Cuts Price Target to $2.50 From $5. Nov. 16. camber energy stock forecast Mar 30, 2021 ... Our mission if to get everyone investing by making it simple and commission-free. The app gives access to a wide range of stocks, ETFs and ...8/24/2022. Find the latest Evelo Biosciences, Inc. (EVLO) stock quote, history, news and other vital information to help you with your stock trading and investing.